Yi Zhang

机构：Zhongyuan University of Technology, Tianjin Medical University General Hospital, Zhengzhou University, Henan Academy of Sciences, First Affiliated Hospital of Zhengzhou University · ORCID：0000-0001-9861-4681

发表论文 2213 篇 · 总被引 100192 次 · h-index 105

代表论文

• H2AFY2 suppresses exhaustion and enhances antitumor activity of CAR-T cells through transcriptional and epigenetic modifications (2026 · Cancer Immunology Research)
• Figure S9 from CAR T Cells Engineered to Secrete IFNκ Induce Tumor Ferroptosis via an IFNAR/STAT1/ACSL4 Axis (2026)
• Figure S8 from CAR T Cells Engineered to Secrete IFNκ Induce Tumor Ferroptosis via an IFNAR/STAT1/ACSL4 Axis (2026)
• Table S1 from Peripheral Blood–Derived PD-1/CD28–CD19 CAR–Modified PD-1<sup>+</sup> T-Cell Therapy in Patients with Solid Tumors (2026)
• Figure S1 from CAR T Cells Engineered to Secrete IFNκ Induce Tumor Ferroptosis via an IFNAR/STAT1/ACSL4 Axis (2026)
• Figure S3 from Peripheral Blood–Derived PD-1/CD28–CD19 CAR–Modified PD-1<sup>+</sup> T-Cell Therapy in Patients with Solid Tumors (2026)